Analysis of the Lipid Profile and Atherogenic Risk during Androgen Deprivation Therapy in Prostate Cancer Patients

Publisher： Karger

E-ISSN： 1423-0399|90|1|41-44

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.90, Iss.1, 2012-12, pp. : 41-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolic changes in patients with prostate cancer during androgen deprivation therapy

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 25, Iss. 1, 2018-01 ,pp. : 45-53

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quality of life in patients with high‐risk prostate cancer improves with shorter course of androgen deprivation therapy

By  

CANCER, Vol. 121, Iss. 7, 2015-04 ,pp. : 971-971

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increased risk of a herpes zoster attack in patients receiving androgen deprivation therapy for prostate cancer

By  

ANDROLOGIA (ELECTRONIC), Vol. 50, Iss. 2, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Androgen Deprivation Therapy in Prostate Cancer - Current Status in M1 Patients

By  

Oncology Research and Treatment, Vol. 38, Iss. 12, 2015-0 ,pp. : 646-652

Karger

Access to resources Recommend Favorite

Current trends for the use of androgen deprivation therapy in conjunction with radiotherapy for patients with unfavorable intermediate‐risk, high‐risk, localized, and locally advanced prostate cancer

By  

CANCER, Vol. 120, Iss. 11, 2014-06 ,pp. : 1620-1629

John Wiley & Sons Inc

Access to resources Recommend Favorite